167 related articles for article (PubMed ID: 28764965)
1. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
Madbouly Taha N; Salah A Yousof HA; El-Sayed SH; Younis AI; Ismail Negm MS
Exp Parasitol; 2017 Oct; 181():57-69. PubMed ID: 28764965
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
Baishanbo A; Gargala G; Duclos C; François A; Rossignol JF; Ballet JJ; Favennec L
J Antimicrob Chemother; 2006 Feb; 57(2):353-5. PubMed ID: 16361328
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
4. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.
Viel H; Rocques H; Martin J; Chartier C
Parasitol Res; 2007 Dec; 102(1):163-6. PubMed ID: 17874133
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
7. Effect of immunosuppression on the course of cryptosporidiosis experimentally.
Toulah FH; El Shafei AA; Al-Rashidi HS
J Egypt Soc Parasitol; 2012 Dec; 42(3):649-58. PubMed ID: 23469638
[TBL] [Abstract][Full Text] [Related]
8. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
[TBL] [Abstract][Full Text] [Related]
9. Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).
Gargala G; François A; Favennec L; Rossignol JF
Antimicrob Agents Chemother; 2013 Jun; 57(6):2821-3. PubMed ID: 23478972
[TBL] [Abstract][Full Text] [Related]
10. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.
Amadi B; Mwiya M; Sianongo S; Payne L; Watuka A; Katubulushi M; Kelly P
BMC Infect Dis; 2009 Dec; 9():195. PubMed ID: 19954529
[TBL] [Abstract][Full Text] [Related]
11. Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant?
Faraci M; Cappelli B; Morreale G; Lanino E; Moroni C; Bandettini R; Terranova MP; Di Martino D; Coccia C; Castagnola E
Pediatr Transplant; 2007 Feb; 11(1):113-6. PubMed ID: 17239134
[TBL] [Abstract][Full Text] [Related]
12. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species.
Rossignol JF; Kabil SM; el-Gohary Y; Younis AM
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):320-4. PubMed ID: 16527695
[TBL] [Abstract][Full Text] [Related]
13. Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.
Costa LB; JohnBull EA; Reeves JT; Sevilleja JE; Freire RS; Hoffman PS; Lima AA; Oriá RB; Roche JK; Guerrant RL; Warren CA
J Parasitol; 2011 Dec; 97(6):1113-20. PubMed ID: 21711105
[TBL] [Abstract][Full Text] [Related]
14. A canine model of experimental infection with Cryptosporidium canis.
Cui Z; Dong H; Wang R; Jian F; Zhang S; Ning C; Zhang L
Exp Parasitol; 2018 Dec; 195():19-23. PubMed ID: 30261189
[TBL] [Abstract][Full Text] [Related]
15. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Moustafa MA
J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
[TBL] [Abstract][Full Text] [Related]
16. [Intestinal pathological changes of Kunming mice infected by Cryptosporidium and the therapeutic efficacy of spiramycin on infected mice].
Wang D; Zhang YY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):225-8. PubMed ID: 25223061
[TBL] [Abstract][Full Text] [Related]
17. ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
Abaza BE; Hamza RS; Farag TI; Abdel-Hamid MA; Moustafa RA
J Egypt Soc Parasitol; 2016 Dec; 46(3):683-692. PubMed ID: 30230765
[TBL] [Abstract][Full Text] [Related]
18. Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.
Rossignol JF
Aliment Pharmacol Ther; 2006 Sep; 24(5):887-94. PubMed ID: 16918894
[TBL] [Abstract][Full Text] [Related]
19. Nitazoxanide.
Parashar A; Arya R
Indian Pediatr; 2005 Nov; 42(11):1161-5. PubMed ID: 16340060
[No Abstract] [Full Text] [Related]
20. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
